Nifidipine may be most effective intervention for stable angina

Data presented at the October 16 Asia-Pacific symposium in Seoul showed that Bayer's Adalat (nifedipine) reduces the risk of coronary artery disease, explained Professor George Nole from the University of Zurich, department of cardiology.

Citing the long-term clinical outcome of a large study ACTION (A Coronary Disease Trial Investigating Outcome with Nifedipine), he said prolonged treatment...